Mirum Pharmaceuticals, Inc.
MIRMNASDAQHealthcare● Active
$93.59
+$0.11(+0.11%)
Market Cap$4.7B
P/E Ratio—
52W High$114.99
52W Low$47.15
Mirum Pharmaceuticals, Inc. (MIRM) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MIRM · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.38B | $0.28B | $0.29B | $0.15B | $0.16B |
| Net Receivables | $0.12B | $0.08B | $0.07B | $0.02B | $0.00B |
| Inventory | $0.02B | $0.02B | $0.02B | $0.01B | $0.00B |
| Total Current Assets | $0.55B | $0.39B | $0.39B | $0.19B | $0.17B |
| PP&E Net | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.26B | $0.25B | $0.25B | $0.06B | $0.02B |
| Total Assets | $0.84B | $0.67B | $0.65B | $0.35B | $0.29B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Current Liabilities | $0.21B | $0.13B | $0.09B | $0.06B | $0.04B |
| Long-Term Debt | $0.31B | $0.31B | $0.31B | $0.00B | $0.00B |
| Total Liabilities | $0.53B | $0.45B | $0.40B | $0.21B | $0.17B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.67B) | ($0.64B) | ($0.56B) | ($0.39B) | ($0.26B) |
| Total Stockholders Equity | $0.31B | $0.23B | $0.25B | $0.14B | $0.12B |
| Total Liab & Equity(computed) | $0.84B | $0.67B | $0.65B | $0.35B | $0.29B |
| Debt Summary | |||||
| Total Debt | $0.32B | $0.32B | $0.31B | $0.00B | $0.00B |
| Net Debt | $0.02B | $0.10B | $0.02B | ($0.03B) | ($0.03B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Mirum Pharmaceuticals, Inc. data
About Mirum Pharmaceuticals, Inc. (MIRM) Balance Sheet
Mirum Pharmaceuticals, Inc. (MIRM) balance sheet shows total assets of $0.84B with cash of $0.38B. Total liabilities are $0.53B, total debt $0.32B, and stockholders equity $0.31B.
Frequently asked questions
MIRM · 4 questionsMirum Pharmaceuticals, Inc. has total debt of $0.32B with net debt of $0.02B.
MIRM total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10